Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02069743 · ClinicalTrials.gov registry record · NA

Pain Management in Cancer Patients Using a Mobile Application

A NA study of Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
110
Enrollment target
2
Study locations

NCT02069743: Completed NA study of Cancer, sponsored by Massachusetts General Hospital.

NCT02069743 is a NA study of Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 110 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02069743, a NA study of Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
2
Study locations

Study Summary

The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. This study is a randomized controlled trial to evaluate the effect of this mobile-based intervention. The investigators' hypothesis is that subjects randomized to the intervention group will have a reduction in pain and pain-related hospitalizations.

Conditions Studied

Cancer

Interventions

  • OTHER ePAL Mobile Application

Study Locations (2)

Massachusetts

  • The Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2014-02
Est. Completion 2020-09
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02069743

The ClinicalTrials.gov registry entry for NCT02069743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which ePAL Mobile Application is the first listed.

NCT02069743 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT02069743 about?

NCT02069743 is a clinical study titled "Pain Management in Cancer Patients Using a Mobile Application". The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. This study is a randomized controlled trial to evaluate the effect of this mobile-based intervention. The investigators' hypothesis is that subjects randomized to the in...

What is the current status of trial NCT02069743?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2014-02. Estimated completion is 2020-09.

What conditions does trial NCT02069743 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02069743?

The interventions under investigation include: ePAL Mobile Application (OTHER).

Who is sponsoring clinical trial NCT02069743?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02069743 being conducted?

This trial has 2 study locations across Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.